Successful application of tissue-engineered skin to refractory ulcers

Clinical and Experimental Dermatology

Volumn 32, Issue 6, 2007, Pages 699-701

  Nie, X ^a   Cai, J K ^b   Yang, H M ^c   Xiao, H A ^c   Wang, J H ^d   Wen, N ^b   Zhang, Y J ^a   Jin, Y ^a,e  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Xi'An Railway   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

^e Department of Oral and Maxillofacial Surgery   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; DECUBITUS; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LAVAGE; MALE; PRIORITY JOURNAL; SAFETY; THERAPY EFFECT; TISSUE ENGINEERING; ULCER HEALING; WOUND;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC FOOT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PRESSURE ULCER; RETREATMENT; SKIN ULCER; SKIN, ARTIFICIAL; TISSUE ENGINEERING; TREATMENT OUTCOME; WOUND HEALING;

EID: 35348968383     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02519.x     Document Type: Article

References (9)

1. Falanga V. Commentary: advances in wound care. Are we there yet? Wound 2000 12 : 51 2.
2. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multi-center clinical trial. Diabetes Care 2001 24 : 290 5.
3. Still J, Glat P, Silverstein P et al. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns 2003 29 : 837 41.
4. Bell E, Ehrlich HP, Buttle DJ et al. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981 211 : 1052 4.
5. Aristidis V, Vincent F, David G et al. Graftskin, a human skin equivalent, is effective in the management of noninfected neuopathic diabetic foot ulcer. Diabetes Care 2001 24 : 290 5.
6. Sabolinski ML, Alvarez O, Auletta M et al. Cultured skin as a 'smart material' for healing wounds: experience in venous ulcers. Biomaterials 1996 17 : 311 20.
7. Wang J, Jin Y, Guo Z et al. Expression of basic fibroblast growth factor and fibronectin in tissue engineering skin allograft during healing process. Hua Xi Kou Qiang Yi Xue Za Zhi 2003 21 : 41 3.
8. Peter S, Olivier G, Jesus M. An intrinsic antibiotic mechanism in wounds and tissue-engineered skin. J Invest Dermatol 2001 116 : 471 2.
9. Falanga V, Margolis D, Alvarez O et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 1998 134 : 293 300.